E R M de Haas
Overview
Explore the profile of E R M de Haas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ottevanger R, de Bruin D, Willemze R, Jansen P, Bekkenk M, de Haas E, et al.
Br J Dermatol
. 2021 Mar;
185(2):434-435.
PMID: 33690948
No abstract available.
2.
Melchers R, Willemze R, Bekkenk M, de Haas E, Horvath B, van Rossum M, et al.
J Eur Acad Dermatol Venereol
. 2019 Nov;
34(2):260-266.
PMID: 31715046
Background: Lymphomatoid papulosis (LyP) can be associated with other haematological malignancies (HM), but reported percentages vary from 20% to over 50%. Objective: To evaluate the frequency and prognostic significance of...
3.
Chung Y, van der Sande A, de Roos K, Bekkenk M, de Haas E, Kelleners-Smeets N, et al.
J Eur Acad Dermatol Venereol
. 2019 Aug;
34(2):274-278.
PMID: 31423673
Background: Several smartphone applications (app) with an automated risk assessment claim to be able to detect skin cancer at an early stage. Various studies that have evaluated these apps showed...
4.
Melchers R, Willemze R, Bekkenk M, de Haas E, Horvath B, van Rossum M, et al.
Br J Dermatol
. 2018 Mar;
179(3):724-731.
PMID: 29494757
Background: There is no consensus on the treatment of multifocal primary cutaneous anaplastic large cell lymphoma (C-ALCL). Radiotherapy (RT) and methotrexate (MTX) are the current treatment options, but their efficacy...
5.
Kessels J, Kreukels H, Nelemans P, Roozeboom M, Van Pelt H, Mosterd K, et al.
Br J Dermatol
. 2017 Sep;
178(5):1056-1063.
PMID: 28886209
Background: Basal cell carcinoma (BCC) is the most common type of skin cancer and incidence rates are increasing. Photodynamic therapy (PDT) is a frequently used treatment, especially for superficial BCC...
6.
van Santen S, van Doorn R, Neelis K, Daniels L, Horvath B, Bruijn M, et al.
Br J Dermatol
. 2017 Jan;
177(1):223-228.
PMID: 28132406
Background: Folliculotropic mycosis fungoides (FMF) is an aggressive variant of mycosis fungoides (MF) and generally less responsive to standard skin-directed therapies (SDTs). Recent studies distinguished indolent (early-stage FMF) and more...
7.
Reinders M, Terra J, Reyners A, Aarts M, de Haas E, Mosterd K
Ned Tijdschr Geneeskd
. 2016 Dec;
160:D187.
PMID: 28000572
The development of the hedgehog pathway inhibitor vismodegib provides a new treatment option for metastasised and locally advanced basal cell carcinoma in which surgical excision or radiotherapy is contraindicated. Only...
8.
9.
Smijs T, Jachtenberg J, Pavel S, Bakker-Schut T, Willemse-Erix D, de Haas E, et al.
J Eur Acad Dermatol Venereol
. 2013 Nov;
28(11):1492-9.
PMID: 24286616
Background: Onychomycosis is worldwide the most prevalent infection of the nail. It is mainly caused by the dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes and to a lesser extent Trichophyton tonsurans....
10.
Middelburg T, de Bruijn H, Tettero L, van der Ploeg van den Heuvel A, Neumann H, de Haas E, et al.
J Photochem Photobiol B
. 2013 Jul;
126:26-32.
PMID: 23892187
Vascular responses to photodynamic therapy (PDT) may influence the availability of oxygen during PDT and the extent of tumor destruction after PDT. However, for topical PDT vascular effects are largely...